


















































Purpose	 of	 review:	 In	 this	 review,	 we	 provide	 a	 general	 overview	 of	 recent	 bioengineering	
breakthroughs	 and	 enabling	 tools	 that	 are	 transforming	 the	 field	 of	 regenerative	medicine.	We	
focus	on	 five	key	areas	 that	are	evolving	and	 increasingly	 interacting	 including	mechanobiology,	












technological	 advances	 but	 also	 enabling	 a	 conceptual	 leap	 focused	 on	 targeting	 regenerative	







or	 mechanobiology	 continue	 to	 expand	 the	 field	 of	 bioengineering.	 Today,	 the	 field	 of	
bioengineering	 is	 a	 testament	 to	 the	 possibilities	 of	 interdisciplinary	 research.	 Regenerative	
medicine	 is	 a	 particularly	 interesting	 target	 for	 the	 development	 and	 application	 of	 novel	
bioengineering	 solutions.	 The	 inherent	 biological	 and	 molecular	 complexity,	 multi-scale	
organizations,	and	spatio-temporal	features	of	regenerative	processes	can	be	tackled	through	an	
ensemble	of	technological	angles.	For	example,	most	regenerative	challenges	can	now	be	tackled	
through	 a	 holistic	 understanding	 of	 biological	 events,	molecular	 design,	 selective	monitoring	 or	
sensing,	and	the	capacity	to	numerically	simulate	events	to	predict	or	optimize	performance.	This	
cooperative	 strategy	 is	 resulting	 in	 ever	 more	 integrated	 therapeutic	 approaches	 that	 are	
redefining	 the	 traditional	 view	 of	 implants,	 devices,	 drugs,	 or	 biomaterials.	 In	 this	 review,	 we	
attempt	 to	 provide	 a	 general	 overview	 of	 work	 being	 conducted	 in	 recent	 years	 in	 five	 key	






In	 the	 body	 cells	 encounter	 a	 dynamic	 environment.	 To	 respond	 to	 chemical	 and/or	 physical	
stimuli,	 cells	 reorganize	 their	 cytoskeleton	and	alter	 their	 function.	 The	 current	paradigm	states	
that	cells	have	the	ability	to	constantly	probe	their	environment.	They	do	so	by	exerting	minute	
forces	 to	 sense	 the	 physical	 properties	 of	 their	 matrix.	 This	 process,	 known	 as	
mechanotransduction,	 takes	 place	 at	 the	 sites	 of	 cell	 adhesion	 and	 leads	 to	 the	 activation	 of	
signalling	cascades	to	control	cell	function.	Similarly,	the	lack	of	appropriate	physical	cues	leads	to	
altered	 cellular	 states,	 as	 observed	when	 isolated	 cells	 are	 cultured	 in	 vitro	 in	 plastic	 dishes.	 In	
these	 conditions,	 several	 cell	 types	 dedifferentiate,	 and	 stem	 cells	 lose	 their	 self-renew	 and	
progressively	enter	senescence.		
	
Matrix	 stiffness	 as	 relevant	 physical	 stimulus	 to	 control	 stem	 cell	 differentiation	 was	 first	
highlighted	by	Engler	et	al	[1].	Long	term	culture	of	stem	cells	on	matrices	with	stiffness	similar	to	
bone	 would	 upregulate	 genes	 and	 express	 protein	 characteristic	 of	 osteogenic	 differentiation.	
Similarly,	matrices	with	stiffness	of	muscle	or	brain	would	result	in	myogenesis	and	neurogenesis,	
respectively.	Such	cell	fate	decisions	require	the	modulation	of	myosin-II	contractility.	A	plethora	
of	 studies	 later	explored	 the	use	of	other	materials	 to	generate	matrices	with	 tunable	 stiffness,	
including	 extracellular	matrix	 (ECM)	 protein-based	 gels,	 polysaccharide-based	 alginate	 gels,	 and	
non-natural	 polymeric	 gels,	 such	 as	 polyacrylamide.	 Since	 the	 later	 are	 chemically	 inert,	 cell	









from	 surface	 properties,	 and	 observed	 similar	 differentiation	 patterns	 to	 those	 found	 using	
synthetic	gels.	Studies	culturing	cells	 inside	3D	hydrogels	have	confirmed	 that	matrix	mechanics	
does	 also	 control	 cell	 fate	 in	 a	 cellular	 environment	more	 similar	 to	 tissue.	 Huebsch	et	 al.	 first	
reproduced	 in	3D	alginate	gels	the	results	previously	found	 in	2D	polyacrylamide	gels	 [5].	Again,	
when	 cultured	 within	 matrices	 whose	 stiffness	 mimicked	 bone	 or	 adipose	 tissue,	 stem	 cells	











exists	 but	 rather	 a	 myriad	 of	 studies	 assessing	 the	 effect	 of	 a	 particular	 loading	 regime.	 To	




Modulation	 of	 cell	 spread	 area	 and	 shape	 using	 micropatterning	 is	 also	 considered	 within	 the	




assembly	and	signalling	via	RhoA	and	Rock	 [16,	14].	Along	 these	 lines,	disruption	of	actomyosin	
stress	 fibers	 by	 chemical	means	 also	 leads	 to	 adipogenic	 or	 neurogenic	 differentiation	 [17-19].	









in	 converting	 the	physical	 signal	 into	a	 chemical	 signal.	 Candidate	proteins	 include	 the	YAP/TAZ	
pathway,	which	has	been	suggested	as	a	hub	 for	 the	conversion	of	mechanical	 information	 into	
chemical	 information.	 YAP/TAZ	 is	 broadly	 implicated	 in	 cell	 fate	 decisions,	 and	 studies	 using	
mechanical	 stimuli	 as	 diverse	 as	 modulation	 of	 cell	 spread	 area	 [20],	 matrix	 stiffness	 [21]	 or	
mechanical	loading		[22]	have	all	identified	YAP/TAZ		as	key	player.	Increased	cytoskeletal	tension	
is	 also	 associated	 with	 increases	 in	 laminA	 expression	 and	 its	 phosphorylation,	 resulting	 in	
translocation	 of	 retinoic	 acid	 receptor	 γ	 (RARG)	 to	 the	 nucleus	 [21]	 and	 the	 activation	 of	 the	
retinoic	acid	signalling	pathway.	Finally,	 increased	actin	polymerization	 levels	(or	specifically,	the	




[23],	 adipose	 [24],epidermal	 [13],	 embryonic	 [25],	 and	 neural	 [26].	 Recent	 studies	 have	 further	
assessed	 the	 fate	and	 therapeutic	 capabilities	of	mechanically-conditioned	 cells	when	used	as	 a	




There	 are	 still	 other	 avenues	 to	 explore	 concerning	 the	 physical	 properties	 of	 the	 cellular	
environment.	Synthetic	matrices	are	treated	as	purely	elastic	materials	than	can	be	fully	described	
with	a	 single	mechanical	parameter,	Young’s	modulus.	Recent	 studies	have	explored	 the	 role	of	
viscoelasticity	as	a	cue	for	differentiation	[28].	Similarly,	other	‘advanced’	mechanical	behaviours	
such	 as	 non-linear	 elasticity	 (the	 fact	 that	 a	 material	 may	 feel	 stiffer	 when	 pulled	 harder)	 or	
mechanical	 anisotropy	 are	 prevalent	 in	 native	 tissue	 and	 should	 be	 considered	 as	 plausible	
mechanical	 cues	 in	 situ.	 Secondly,	mechanical	 cues	have	been	mostly	 designed	as	 uniform,	 and	







undergo	 commitment	 and	 cannot	 be	 later	 re-directed	 to	 a	 different	 lineage	 [1].	 A	 similar	
mechanical	memory	has	been	observed	when	stem	cells	are	stimulated	with	mechanical	 loading	
regimes	 [29].	 This	 phenomenon	 should	 force	 us	 to	 re-examine	 all	 stages	 of	 stem	 cell-based	








the	 top-down	 using	 advanced	 fabrication	 techniques	 [31].	 Today’s	 biomaterials	 can	 be	
programmable,	 information-rich,	 reversible,	 molecularly-designed	 or	 tissue-derived,	 bioactive,	
biomimetic,	and/or	capable	of	exhibiting	multiple	functions.	In	this	section,	we	provide	a	taste	of	




A	major	 goal	 in	 RM	 is	 the	 capacity	 to	 stimulate	 biological	 responses	with	 temporal	 and	 spatial	
control	while	 exhibiting	 functional	 physical	 properties.	With	 this	 in	mind,	 Yu	et	 al.	 developed	 a	
polysiloxane	membrane	that	acts	as	a	“second	skin”	and	restores	skin	function	thanks	to	its	bulk	
elasticity,	 contractility,	 adhesion,	 and	 breathability	 (Figure	 2a)	 [32].	 Material	 coatings	 can	 also	
provide	 such	 tissue-compatibility.	 For	 example,	 thin	 flexible	 perfluorocarbon	 layers	 have	 been	
developed	to	prevent	thrombosis	and	formation	of	bacterial	layers	[33].	Functionality	may	also	be	
enhanced	 not	 only	 by	 the	 properties	 of	 individual	 materials,	 but	 on	 their	 synergistic	 effect.	 A	





for	 example	 recombinant	 technologies,	 facilitates	 the	 integration	 of	mechanical	 properties	 and	
biomolecular	 signaling.	 For	 example,	 Tejeda-Montes	 et	 al.,	 developed	 an	 elastin-like	 polymer	
membrane	with	outstanding	mechanical	properties	[36]	and	the	capacity	to	enhance	osteoblastic	






Tissue	 regeneration	 is	 characterized	by	an	orchestrated	 set	of	dynamic	processes	where	a	wide	
variety	 of	 cells	 and	 structural	 and	 signaling	 molecules	 interact	 in	 a	 3D	 space.	 In	 this	 scenario,	





and	 signaling	 properties	 to	 study	 the	modulation	 of	 cells	 (Figure	 2b)	 [45].	 The	 past	 decade	 has	
seen	 a	 particular	 emphasis	 on	 the	 understanding	 of	matrix	 stiffness	 to	 direct	 cell	 behavior,	 an	





The	 last	 two	 decades	 have	 seen	 a	 growing	 interest	 in	 the	 development	 of	 supramolecular	
materials	based	on	self-assembly	due	to	the	possibility	to	fabricate	biomaterials	that	are	modular	
and	 tuneable	 and	 can	 be	 systematically	modified	 to	 enable	 properties	 such	 as	 responsiveness,	
bioactivity	 and	 multifunctionality	 [49].	 Self-assembling	 systems	 based	 on	 peptides	 have	 been	
particularly	popular	and	a	large	variety	of	excellent	reviews	have	been	published	on	this	topic	[50,	
51].	 The	 main	 advantage	 of	 these	 systems	 is	 the	 possibility	 to	 use	 bioinspired	 molecules,	
selectively	 interact	with	 biological	 ones,	 and	 easily	 engineer	 systematic	modifications	 to	 create	
materials	 that	 stimulate	 biological	 processes,	 recreate	 complex	 bioactive	 molecules,	 or	 tune	
environmental	 conditions.	 For	 example,	 using	 Fmoc-peptides,	 Alakpa	et	 al.,	 developed	 a	 simple	
self-assembling	 system	 with	 tuneable	 stiffness	 capable	 of	 directing	 cell	 behavior	 on	 demand	
(Figure	 2c)	 [52].	 Others	 have	 used	 self-assembling	 nanofibres	 to	 selectively	 recruit	 and	 deliver	
growth	 factors	 (GFs)	 for	 bone	 regeneration	 [53],	 cells	 to	 treat	 ischemic	 cardiovascular	 diseases	
[54],	or	even	mimic	complex	molecules	such	as	growth	factors	[41]	or	glycosaminoglycans	[55].	
	
Future	self-assembling	systems	are	expected	to	provide	a	 technological	and	 functional	 leap	 that	
will	 take	 us	 beyond	 precise	 nanostructures	 and	 into	 dynamic	 materials	 exhibiting	 remarkable	
properties	such	as	self-healing	or	the	capacity	to	grow	and	adapt.	These	biomaterials	will	emerge	
from	 combinatorial	 approaches	 capable	 of	 optimizing	molecular	 interactions	 through	 a	 natural	
selection	 of	 peptides	 [56]	 or	 proteins	 [57]	 and	 utilize	 dynamic	 intermolecular	 processes.	 For	
example,	Inostroza-Brito	et	al.,	have	introduced	a	peptide-protein	supramolecular	system	capable	





The	functionality	of	 these	materials	 for	 regenerative	medicine	will	also	depend	on	the	way	they	
are	 processed.	 In	 additive	 manufacturing,	 for	 example,	 a	 large	 variety	 of	 bioinks	 are	 being	
developed	 with	 the	 goal	 of	 enabling	 bioactivity	 and	 biocompatibility	 while	 fulfilling	 critical	
processing	requirements	[59].	Novel	biofabrication	techniques	are	also	enabling	the	development	
of	 complex	 hydrogel	 materials	 [60].	 For	 example,	 photopatterning	 techniques	 can	 be	 used	 to	
generate	 chemically	 anisotropic	 regions	 containing	 patterns	 of	 peptides	 [61]	 or	 proteins	 [62].	
Another	 versatile	 approach	 includes	 direct-writing	 fabrication,	 which	 has	 been	 used	 to	 pattern	
cellulose	 fibrils	 that	give	rise	 to	dynamically	 reconfigurable	hydrogels	 [63]	or	 to	print	a	hydrogel	
within	 a	 self-healing	 hydrogel	 to	 create	 anisotropic	 environments	 [64].	 The	 capacity	 to	 create	
patterns	within	3D	soft	matter	is	enabling	targeting	of	a	major	challenge	in	regenerative	medicine,	
namely	 the	 generation	 of	 vascularized	 scaffolds.	 Examples	 include	 the	 use	 of	 multiphoton	
micromachining	 to	 create	 cm-deep	 vascularizing	 patterns	 [65]	 or	 bioprinting	 of	 multiple	 inks	
including	cells,	polymers,	and	hydrogels	to	create	vascularized	tissue-like	structures	[66].	A	major	
functional	 breakthrough	 was	 recently	 reported	 by	 Kang	 et	 al.,	 demonstrating	 the	 possibility	 to	
print	 various	polymer	and	hydrogel-based	 inks	with	an	 integrated	 tissue-organ	printer	 (ITOP)	 to	
create	living	human-size	calvarial	bone,	cartilage,	and	skeletal	muscle	[67].	
	
All	 these	 advances	 pave	 the	 way	 for	 an	 exciting	 future	 in	 biomaterials	 design.	 However,	 it	 is	
important	to	keep	 in	mind	that,	while	sophisticated	materials	continue	to	emerge,	most	current	







Delivery	 strategies	 in	 RM	 are	 based	 on	 the	 controlled	 administration	 of	molecular	 regulators	 -	
protein	morphogens	 (e.g.	GFs),	nucleic	acids	 (e.g.	cDNA,	mRNA,	miRNA)	or	small	molecules	 (e.g.	
retinoic	acid,	dexamethasone)	 -	 to	 specific	 cells	or	 tissues	 to	modulate	cell	 fate,	or	 improve	 the	
niche	properties,	and	ultimately	promote	tissue	regeneration.	While	some	molecules	exert	 their	
action	extracellularly	(e.g.	GFs)	by	interacting	with	cell-surface	receptors,	nucleic	acid	therapeutics	
require	 internalization	 to	 access	 intracellular	 targets.	 Physical	 methods	 have	 been	 used	 to	
promote	 intracellular	 delivery	 of	 cargos,	 including	microinjection,	 opto-	 or	 electroporation	 and	
cavitation	 [68].	However,	 these	methods	are	quite	 invasive	as	 they	cause	membrane	disruption,	
being	typically	used	in	in	vitro	and	ex	vivo	strategies.	Clinically,	less	invasive	and	safer	approaches	
are	necessary.	Carrier-based	delivery	 systems	are	 typically	 internalized	by	endocytosis	 and	 their	
physicochemical	properties	(size,	shape,	charge,	ligand	density)	can	be	engineered	to	enhance	the	
delivery	of	anabolic	and	catabolic	factors	into	cells	[69].	In	this	way,	genes	can	be	turned	on	or	off	
to	 promote	 expression	 or	 inhibition	 of	 a	 certain	 protein	 involved	 in	 tissue	 regeneration.	 In	 this	
section,	we	highlight	the	use	of	bioengineering	approaches	to	design	multifunctional	nanocarriers,	
through	multivalency	 [70],	 targeting	and	cell-penetrating	ability	 [71],	 stimuli-responsiveness	 [72,	





genes	 in	a	cell	resulting	 in	 its	conversion	 into	another	cell	type.	A	 landmark	 in	cell	reprograming	
was	reported	by	Yamanaka	et	al.	who	were	able	to	convert	mouse	embryonic	or	adult	fibroblasts	
into	 induced	pluripotent	stem	cells	 (iPSCs)	by	delivering	four	transcription	factors	 (Oct3/4,	Sox2,	
Klf4,	 c-Myc)	 [74].	 The	 transduced	 cells	 showed	 characteristics	 of	 pluripotency,	 indicating	 the	
possibility	to	generate	PSCs	from	somatic	cells	for	applications	in	RM.	Since	viruses	have	specific	
mechanisms	 to	 release	 genetic	 material	 inside	 cells,	 the	 transcription	 factors	 were	 delivered	
through	 retrovirus.	 Since	 the	 pioneering	 work	 of	 Yamanaka,	 similar	 approaches	 were	 used	 to	
manipulate	 cells	 in	 vitro	 and	 then	 transplant	 them	 in	 vivo	 for	 treating	 diseases.	 For	 example,	
Filareto	et	al.	derived	corrected	dystrophic	iPSCs	from	mice	tail-tip	fibroblasts	missing	dystrophin	
and	utrophin,	 proteins	 implicated	 in	muscle	homeostasis.	After	 generating	myogenic	progenitor	
cells	 from	 differentiation	 of	 corrected	 dystrophic	 iPSCs,	 they	 transplanted	 the	 cells	 into	 the	
muscles	of	mice	with	muscular	dystrophy	 [75].	 Immunofluorescence	of	muscle	 sections	 showed	
cell	engraftment	and	expression	of	utrophin.	This	cell-based	therapy	led	to	some	improvements	in	
muscle	 function,	 but	 more	 efficient	 vectors	 are	 required	 to	 deliver	 reprogramming	 and	
differentiation	factors	and	improve	regeneration	outcomes.		
	
Viral-mediated	 transduction	 has	 been	 widely	 used	 in	 cell	 reprogramming,	 but	 the	 potential	
cytotoxicity	 an	 immunogenicity	 of	 viruses	 [76]	 has	 led	 to	 the	 development	 of	 non-viral	 vectors	
(nanocarriers)	 to	 deliver	 cargos	 inside	 cells	 [77].	 Dexamethasone	 (Dex),	 a	 water-insoluble	
glucocorticosteroid,	 has	 been	 used	 as	 a	 supplement	 in	 osteogenic	 medium	 to	 induce	 the	
differentiation	 of	 mesenchymal	 stem	 cells	 (MSCs)	 into	 the	 osteoblastic	 lineage.	 After	 cell	
internalization,	 Dex	 binds	 to	 glucocorticoid	 receptors	 on	 the	 nuclei,	 resulting	 in	 their	 activation	
[78]	 and	 consequent	 expression	 of	 Runx2	 gene	 [79]	 encoding	 a	 protein	 that	 is	 essential	 for	
osteoblastic	differentiation.	Dendrimers	[80]	and	polymeric	micelles	[81]	were	used	to	entrap	this	
hydrophobic	molecule	and	allow	its	sustained	release	intracellularly	in	rMSCs.	However,	for	in	vivo	
delivery	 to	 specific	 cells	 and	 minimizing	 side	 effects	 in	 other	 tissues,	 targeting	 strategies	 are	
necessary.	Santos	et	al.	functionalized	dendrimers	with	peptides,	identified	by	phage	display	and	
with	 high	 affinity	 for	MSCs,	 to	 deliver	 pDNA	 to	 those	 cells	 in	 vitro	 [82].	 Using	 pDNA	 encoding	
enhanced	green	fluorescent	protein	(eGFP)	and	firefly	luciferase	(FLuc),	successful	transfection	of	
cells	was	observed	with	low	levels	of	cytotoxicity.	Although	transfection	efficiency	was	superior	in	
cells	 treated	 with	 peptide-functionalized	 dendrimers,	 cell	 selectivity	 was	 not	 demonstrated.	 A	
similar	 targeting	 strategy	was	 developed	 using	 liposomes	 and	 phage-derived	 peptides	 targeting		
rMSCs	 to	 deliver	 sleeping	 beauty	 transposon	 plasmid	 [83].	 To	 promote	 nuclear	 translocation,	
nuclear	 localization	 signal	 peptides	 were	 also	 incorporated	 in	 the	 nanocarrier	 system.	 The	
identified	peptide	was	shown	to	be	selective	for	rMSCs	and	 improve	transfection	efficiency.	The	
osteogenic	differentiation	of	transfected	MSCs	was	not	affected,	suggesting	that	gene	delivery	can	




In	cell-based	therapies,	 improving	the	properties	of	 the	niche	where	cells	will	be	transplanted	 is	
essential	to	ensure	cell	engraftment.	For	example,	inducing	angiogenesis	locally	can	promote	skin	
wound	healing	and	myocardial	regeneration.	Different	approaches	have	been	exploited	to	induce	
angiogenesis,	 including	 delivery	 of	 angiogenic	 factors	 (e.g.,	 vascular	 endothelial	 GF	 -	 VEGF),	
transplantation	of	endothelial	cells	 (ECs)	or	gene-based	therapies,	but	 it	has	been	challenging	to	
achieve	a	stable	vasculature.	Hubbell	and	co-workers	designed	a	peptide-based	vector	(binding	to	
DNA,	 nucleus	 and	 fibrin)	 to	 deliver	 pDNA	 encoding	 the	 stabilized	 variant	 of	 hypoxia-inducible	
factor,	a	transcription	factor	involved	in	the	regulation	of	various	pro-angiogenic	factors	[84].	The	
ability	 of	 the	 peptide-pDNA	 complexes	 embedded	 in	 a	 fibrin	matrix	 to	 promote	wound	 healing	
was	 tested	 in	 a	 mouse	 model	 of	 full-thickness	 dermal	 wound.	 Histological	 analysis	 showed	
increased	number	of	 ECs	 in	wounds	 treated	with	peptide-pDNA	 system	and	VEGF-A165	 (positive	
control),	when	compared	with	wounds	treated	with	fibrin	alone	(negative	control),	 indicating	an	
enhanced	angiogenic	response.	More	mature	vessels	were	observed	in	the	wounds	treated	with	







autologous	 bone	 grafts.	 To	 promote	 osteointegration	 of	 bone	 implants,	 a	 liposome	 carrier	was	
used	to	deliver	cDNA	for	bone	morphogenetic	protein	2	 (BMP-2)	 into	peri-implant	bone	defects	
[85].	 Immunocytochemistry	 analysis	 showed	 the	 presence	 of	 BMP-2	 in	 cells	 migrating	 into	 the	
defects,	 demonstrating	 the	 successful	 transfection	 of	 cells	 in	 vivo.	 Bone	 regeneration	 was	
significantly	enhanced	in	the	defects	treated	with	liposomes	carrying	BMP-2	gene,	but	not	all	the	
regions	 of	 the	 defect	 showed	 complete	 bone	 healing.	 It	 was	 postulated	 that	 this	 might	 have	
resulted	from	the	 insufficient	number	of	cells	mobilized	to	certain	regions	of	the	defect	and	not	
due	 to	 low	 transfection	efficiency.	This	 suggests	 the	need	 for	a	homing	strategy	 to	 recruit	 stem	
cells	 into	 the	defect	site	using	carriers	 functionalized	with	stem	cell-binding	peptides	derived	by	
phage	display	[86].		
	
Metabolic	 bone	 disorders,	 such	 as	 osteoporosis,	 are	 characterized	 by	 abnormal	 calcium	






formation	 [88],	 they	were	 able	 to	 stimulate	 bone	 formation.	 This	 delivery	 strategy	was	 further	
upgraded	 by	 including	 a	 DNA	 aptamer	 specific	 to	 rat	 osteoblasts	 (CH6)	 on	 the	 surface	 of	 lipid	
nanoparticles	(LNPs,	Figure	3a)	[89].	The	aptamer-functionalized	LPNs	loaded	with	Plekho1	siRNA	
were	shown	to	be	internalized	by	osteoblasts	in	vitro	(Figure	3b).	In	vivo	studies	using	osteopenic	
rats	 (low	 bone	 mineral	 density)	 showed	 enhanced	 bone	 formation	 with	 improved	
microarchitecture	 when	 rats	 were	 treated	 with	 CH6-siRNA-LNPs	 (Figure	 3c)	 as	 compared	 with	
other	groups.	By	selectively	stimulating	bone	formation	without	promoting	bone	resorption,	this	









according	 to	whether	 the	 targets	 are	 labeled	with	markers	 and	whether	 the	monitoring	 can	be	
achieved	in	vivo	[90-93,	86,	94].	In	this	section,	we	will	present	an	overview	of	the	state-of-the-art	
imaging	technologies	 in	stem	cell	 research	and	RM	with	the	emphasis	placed	on	 in	vivo	 imaging	








and	 is	considered	as	the	most	robust	 imaging	technology	 in	clinical	settings.	MRI	can	be	applied	
with	 contrast	 agent	 injection	 or	without	 any	 exogenous	 labels,	 and	 has	 no	 depth	 limitation.	 ii)	
Positron	emission	tomography	 (PET)	 injects	a	positron-emitting	radioactive	 isotope	 incorporated	
in	 a	metabolically	 active	molecule	 such	 as	 fluorodeoxyglucose	 (FDG)	 [98-100].	 In	 the	 circulating	
blood,	 FDG	decays	 by	 emitting	 a	 positron,	which	meets	 an	 electron	 and	produces	 two	photons	
moving	 in	opposite	directions.	PET	has	a	very	high	sensitivity	and	has	no	 limits	 in	 imaging	depth	
and	 therefore	 can	 be	 used	 for	 tracing	 cell	 expressing	 reporter	 proteins,	 but	 requires	 ionizing	
radiation	with	associated	biohazardous	labels.	In	addition,	rapid	image	acquisition	(usually	within	
a	day)	is	needed	for	PET	due	to	the	short	lifetime	of	the	radioligands.	iii)	Single	photon	emission	
tomography	 (SPECT)	 is	 a	 tomography	 technology	 and	 uses	 gamma	 rays	 for	 image	 acquisitions	
[101,	102].	By	collecting	2D	images	using	a	gamma	camera,	3D	images	can	be	reconstructed	based	
on	 multiple	 2D	 scans.	 SPECT	 has	 very	 high	 sensitivity	 and	 the	 tissue	 penetration	 depth	 is	 not	
limited	but	the	spatial	resolution	is	relatively	low.	Similar	to	PET,	SPECT	needs	ionizing	radiations,	
which	may	 impose	 radiation	 risks.	The	main	 limitation	of	SPECT	 is	 that	 the	 short	 lifetime	of	 the	
SPECT	agent	makes	it	only	suitable	for	short-term	cell	tracing.	iv)	Computed	tomography	(CT)	sent	













PAI	 has	 the	 high	 contrast	 and	 good	 specificity	 offered	 by	 optical	methods	 and	 the	 high	 spatial	
resolution	 and	deeper	 penetration	depth	provided	by	 the	ultrasound	modality.	 In	RM	PAI,	 gold	
nanoparticles	 used	 to	 label	 stem	 cells,	 can	 be	 tuned	 to	 have	 strong	 plasmon	 resonance	 at	 the	
excitation	 wavelengths	 to	 enhance	 the	 photoacoustic	 signal.	 ii)	 Optical	 coherence	 tomography	
(OCT)	 uses	 low	 coherence	 light	 to	 acquire	 multiple	 2D	 images	 through	 interferometry	 to	
reconstruct	 3D	 images	 [111-113].	 Although	 in	 most	 applications	 OCT	 is	 used	 as	 a	 label-free	
imaging	 technology,	 for	 stem	cell	 research,	 the	application	of	OCT	 relies	on	exogenous	 contrast	
agents	such	as	magnetic	and	 iron	oxide	particles,	proteins,	dyes,	and	nano-materials	to	enhance	
the	detection	sensitivity	to	molecular	 level.	 iii)	Bioluminescence	imaging	(BLI)	utilizes	native	light	
emissions	 from	 several	 bioluminescent	 organisms,	 e.g.	 the	 substrate	 D-luciferin	 by	 the	 enzyme	
Fluc	 from	 the	North	 American	 Firefly	 [114-116]	 (Figure	 4d).	 BLI	 is	 a	 low-cost	 approach	 offering	
both	high	signal-to-noise	ration	and	sensitivity,	and	has	been	widely	used	in	small	animal	studies.	
The	applications	of	BLI	 include	tracking	hematopoietic	stem	cell	engraftment	and	assessing	stem	
cell	 types.	 However,	 the	 strong	 scattering	 and	 absorption	 of	 the	 tissue	 limits	 the	 penetration	
depth	of	BLI.	iii)	Fluorescence	imaging	uses	an	external	light	source	to	excite	fluorescence	emission	
from	 a	 range	 of	 fluorescent	 labels,	 such	 as	 green	 or	 red	 fluorescent	 proteins	 (GFP	 or	 RFP)	 and	
quantum	 dots	 (QD)	 [117-119].	 The	 fluorescence	 image	 can	 be	 acquired	 by	 collecting	 the	
fluorescence	 emissions	 from	 the	 fluorophores.	 Similar	 to	 BLI,	 the	 penetration	 depth	 of	




For	 the	 in	 vivo	 imaging	 technologies	 reviewed	 above,	 to	 some	 extent,	 they	 are	 limited	 by	 a	
number	 of	 factors,	 such	 as	 the	 radiation	 hazard,	 the	 imaging	 depth	 limited	 by	 the	 tissue	
absorption	and	scattering,	and	reduced	cell	tracking	time.	These	limitations	result	in	low	sensitivity	
and	 specificity,	 and	 limited	 ability	 to	 monitor	 cell	 changes	 and	 therapy	 progresses	 over	 time.	
Multimodality	 imaging	 is	 one	 promising	 direction	 to	 address	 such	 challenges,	 which	 combines	
multiple	imaging	methods	to	achieve	an	improved	imaging	performance	[120].	For	example,	high-
sensitivity	and	low-resolution	methods	such	as	PET	can	be	used	together	with	MRI	to	improve	the	




or	organ	 to	collect	 real-time	 images	and	communicate	with	an	external	device	 through	wireless	
signals	 [124,	125].	 It	 is	 foreseeable	that	 in	vivo	 imaging	will	play	an	 important	role	 in	 future	RM	





The	 ability	 of	 mathematical	 and	 computational	 models	 to	 guide	 experimental	 discovery	 is	
increasingly	appreciated	in	the	field	of	RM,	where	the	term	“in	silico”	is	more	and	more	used	when	
discussing	the	future	of	this	promising	field	[126-128].	This	section	discusses	recent	opportunities	




the	 field	 of	 RM.	 Regenerating	 organs	 requires	 the	 ability	 to	 recreate	 a	 suitable	 physical	 and	
biochemical	 environment	 for	 the	 cells	 to	 grow.	 Elements	 of	 such	 environment	 include	 the	
mechanical	 and	 geometric	 properties	 of	 the	 growth	 substrate,	 the	 transport	 properties	
determining	 the	 rate	 at	which	 nutrients	 and	oxygen	 are	 supplied,	 and	waste	 removed,	 and	 the	
level	 of	 mechanical	 load	 and	 fluid	 shear	 [129,	 128,	 130].	 Without	 the	 framework	 provided	 by	
mathematical	models,	it	would	neither	be	possible	to	quantify	and	predict	these	properties	nor	to	
establish	 a	 link	 between	 macroscopic	 variables	 -	 which	 can	 be	 observed	 and	 controlled	 in	 an	
experiment	-	and	microscopic	variables	that	affect	cell	fate	directly.	
	
An	 example	 of	 this	 link	 is	 offered	 by	 the	 development	 of	 bioengineering	 scaffolds.	 While	 the	





to	computer	 implementations	 (Figure	5a)	 [131].	Validated	simulations	can	offer	 insights,	and	be	
used	 to	 establish	 engineering	 correlations,	 by	 for	 example,	 providing	 the	 local	 transport	
environment	experienced	by	each	single	cell	as	a	function	of	flow	rate	and	ambient	concentration.		
	
Today,	 purely	 mechanical	 phenomena	 related	 to	 bioengineering	 scaffolds	 can	 be	 simulated	
accurately.	 The	 wide	 availability	 of	 software	 to	 convert	 CT	 scans	 into	 a	 computer	 mesh	 (e.g.	
Mimics),	 and	 to	 solve	 the	 relevant	 fluid	 and	 solid	 mechanics	 equations	 (e.g.	 Fluent,	 Abacus),	
renders	 the	 implementation	 of	 a	 simulation	 for	 optimising	 the	 scaffold’s	microstructure	 within	
reach	of	any	modern	bioengineering	 lab.	The	challenge	that	will	probably	occupy	computational	
scientists	 in	 the	 future	 is	 the	 development	 –	 and	 validation	 against	 experiments	 -	 of	 suitable	
models	for	cell	growth,	mobility	and	interaction	[132,	133,	130].			
	




behaviour	 of	 materials	 formed	 by	 soft	 macromolecular	 and	 colloidal	 elements,	 including	 the	
coupling	of	deformation	mechanics,	chemical	reactions,	 fluid	flow,	physico-chemical	effects	such	
as	 swelling,	 phase	 change,	 etc.	 Thanks	 to	 development	 in	 this	 exciting	 discipline,	 our	 ability	 to	




micro-patterning	 technique	 to	 promote	 cell	 colonisation.	 Lithographic	 techniques	 can	 produce	
geometric	 features	 with	 exquisite	 control	 over	 microstructural	 geometry.	 However,	 deploying	





The	 geometry	 of	 these	 patterns	 can	 be	 accurately	 predicted	 based	 on	 the	 theory	 of	 elasto-
capillary	 coalescence,	 which	 has	 been	 the	 subject	 of	 increasing	 interest	 by	 the	 soft	 matter	
community	 recently	 [136].	 Patterning	 through	 wrinkling	 (Figure	 5c-e)	 is	 another	 approach	 that	
heavily	relies	on	recent	applications	of	non-linear	mechanics	theories	to	soft	matter	systems	[137].	
Such	 theories	 enable	 to	 predict	 the	 wavelength	 of	 the	 wrinkles	 with	 extraordinary	 precision,	
enabling	 for	 instance	 to	 design	 the	 spacing	 and	 stiffness	 of	 protrusion	 where	 cells	 can	 anchor	
themselves.	 In	 addition	 to	 provide	 insights	 and	 predictions	 on	 how	 to	 make	 new	 materials,	




A	 second	 opportunity	 is	 the	 realisation	 of	 the	 importance	 of	 algorithmic	 mining	 of	 data	 as	 a	
predictive	 engineering	 tool	 in	 various	 areas	 of	 bioengineering	 [142,	 143].	 Data	 analysis	 is	 not	 a	
new	 discipline.	What	 is	 new	 is	 the	 availability	 of	 inexpensive	 sensors	 (pressure,	 concentration,	





time	 interrogation	 of	 the	 data	 from	 micro-devices	 containing	 cells,	 and	 the	 feedback	 of	 this	
information	 to	 control	 the	 device’s	 operating	 parameters	 two	 important	 elements	 that	 require	
modelling.	 We	 believe	 that	 the	 convergence	 of	 cheap	 and	 robust	 sensing	 and	 imaging	
technologies,	 big	 data	 techniques,	 and	 physics-based	 computations	 could	 bring	 a	 new	 level	 of	
understanding	 of	 the	 complexity	 inherent	 in	 regenerative	 medicine	 constructs,	 particularly	 in	





Novel	 bioengineering	 technologies	 are	 redefining	 how	 we	 view	 and	 tackle	 key	 challenges	 in	
regenerative	medicine.	We	 have	 provided	 a	 general	 overview	 of	 five	 dynamic	 and	 increasingly	
evolving	areas	that	are	shaping	the	next	generation	of	regenerative	medicine	therapies	aiming	to	
provide	 more	 selective	 cell-material	 interactions,	 higher	 precision,	 faster	 monitoring,	 more	
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Figure	 2	 (a)	 Comparative	 image	of	 the	polysiloxane	membrane	 serving	 as	 a	 “second	 skin”	 (XPL)	
capable	 of	 restoring	 natural	 function	 [33].	 (b)	 Organoid	 structures	 generated	 using	 a	 modular	
synthetic	 hydrogel	 with	 tuneable	 matrix	 elasticity	 and	 signaling	 properties	 [45].	 (c)	 Hydrogels	





Figure	 3	 Stimulation	 of	 bone	 regeneration	 through	 targeted	 carrier-mediated	 delivery	 of	 genes	
silencing	inhibitors	of	osteogenesis:	(a)	Schematic	illustrating	the	preparation	of	lipid	nanoparticles	





proximal	 tibia	 of	 osteopenic	 ovariectomized	 (OVX)	 rats	 showing	 the	 3D	microstructure	 of	 bone	
before	and	after	administration	of	different	siRNA	formulations	(scale	bar	=	1	mm)	[89].	
	
Figure	 4	 Examples	 of	 imaging	 modalities	 for	 regenerative	 medicine	 and	 stem	 cell	 therapy:	 a)	
Representative	MR	 images	 for	mice	 receiving	 hMSc	 at	 Day	 0	 and	 Day	 16.	 F-MRI	 quantification	
correlates	very	well	with	the	number	of	 implanted	cells	at	Day	0	and	shows	detectable	hMSc	at	
Day	 16	 [146].	 (b)	 3D	 Longitudinal	 in	 vivo	 images	 by	 combined	 ultrasound	 and	 Photoacoustic	




Figure	 5	 (a)	Modelling	based	on	computational	 fluid	dynamics	 simulation	of	a	 scaffold	 for	bone	
regeneration	 [131];	 (b)	 Scaffold	 for	 mesenchymal	 stem	 cells	 formed	 by	 elasto-capillary	
coalescence	of	carbon	nanotube	fibres	(arrow	heads:	collapsed	and	laid	CNTs,	arrows:	CNTs	that	
were	shrunk	to	form	the	razor-sharp	peaks)	[135].	(c,	d)	surface	patterning	through	thin	soft	layer	
wrinkling	[137].	(e)	Finite	element	simulation	of	a	buckled	cylindrical	shell	[148].	
	
	
